# 4Moving Biotech: Phase 2 study completed, 130 enrolled (Knee Osteoarthritis, Synovitis of Knee)

**Score:** 100/100

| Field | Value |
|---|---|
| Sponsor | 4Moving Biotech |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis |
| NCT ID | NCT07225829 |
| Phase | Phase 2 |
| Status | completed |
| Conditions | Knee Osteoarthritis; Synovitis of Knee |
| Intervention types | drug |
| Target enrollment | 130 |
| Site countries | United States, Canada, Denmark, France, Poland, Spain |
| Posted | 2025-11-10 |
| Planned start | 2025-06-17 |
| Event | Completed |
| Event date | 2026-10-19 |
| Last update posted | 2026-10-23 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Completed: closeout, analysis and the next study ahead.
- Phase 2: multi-site, larger budget.
- 130 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07225829). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.